Announcement Össur hf. No. 5/2011
Reykjavik, 11 March 2011
Delisting from NASDAQ OMX Iceland accepted
NASDAQ OMX Iceland has today accepted Össur's request from 15 November 2010 to
remove the shares from trading on NASDAQ OMX Iceland. The removal will be
effective as of close of trading on 25 March 2011.
NASDAQ OMX in Iceland has decided, at its own initiative and without
consultation with the Company, to create a market for the shares in ISK as of
28 March 2011.
No actions are required from shareholders.
Össur's trading platform for the shares is NASDAQ OMX Copenhagen.
For further information, please contact:
Jón Sigurðsson, President & CEO Tel: +354 515 1300
Hjörleifur Pálsson, CFO Tel: +354 515 1300
About Össur
Össur (OMX: OSSR) is a global leader in non-invasive orthopaedics that help
people live a life without limitations. Its business is focused on improving
people's mobility through the delivery of innovative technologies within the
fields of braces, supports, prosthetic limbs and compression therapies. A
recognized "Technology Pioneer", Össur invests significantly in research and
product development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes are further
empowered via Össur's educational programs and business solutions. Headquartered
in Iceland, Össur has major operations in the Americas, Europe and Asia, with
additional distributors worldwide.
Forward-Looking Statements
This press release includes "forward-looking statements" which involve risks and
uncertainties that could cause actual results to differ materially from results
expressed or implied by these statements. Össur hf. undertakes no obligation and
does not intend to update these forward-looking statements to reflect events or
circumstances occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date of this press release. All forward-looking statements are qualified in
their entirety by this cautionary statement.
[HUG#1496307]